UBS Group’s Oculus Innovative Sciences, Inc. OCLSW Stock Holding History

UBS Group’s Portfolio OCLSW Stock Details OCLSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,151	Closed	-$1K	–	8224
2016 Q2	$1K	Buy	+3,151	New	+$782	﹤0.01%	7633
2016 Q1	–	Sell	-4,052	Closed	-$1K	–	8628
2015 Q4	$1K	Buy	+4,052	New	+$1.19K	﹤0.01%	8237
2015 Q3	–	Sell	-1,982	Closed	-$1K	–	8892
2015 Q2	$1K	Buy	+1,982	New	+$609	﹤0.01%	8384

Other funds holding OCLSW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

UBS Group's OCLSW Position: Q3 2016 in Review

UBS Group sold out of Oculus Innovative Sciences, Inc. (OCLSW) in Q3 2016, closing a stake of 3,151 shares — an estimated $1K sold.

UBS Group first reported a position in OCLSW in Q2 2015 and held it in 3 quarters. The position peaked at $1K in Q2 2016. 5 funds tracked by Wall St. Rank hold OCLSW as of Q3 2016.

UBS Group reported no remaining Oculus Innovative Sciences, Inc. position as of Q3 2016 after selling out during the quarter.
UBS Group sold 3,151 Oculus Innovative Sciences, Inc. shares in Q3 2016, an estimated $1K.
UBS Group first reported a position in Oculus Innovative Sciences, Inc. in Q2 2015 and held it in 3 quarters.
UBS Group's Oculus Innovative Sciences, Inc. position peaked at $1K in Q2 2016.
5 funds tracked by Wall St. Rank held Oculus Innovative Sciences, Inc. as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.